#news #biotech Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson’s disease

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson’s disease .Pfizer’s neuroscience spinoff, Cerevel Therapeutics, is bringing on Otsuka’s Raymond Sanchez, M.D., to serve as its new chief medical officer and take forward development of its late-stage programs for Parkinson’s disease and epilepsy into phase 3.

from FierceBiotech: Biotech https://ift.tt/2T5WY0M

#news #biotech Using Bristol-Myers’ popular leukemia drug to improve anti-PD-1 cancer immunotherapy

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Using Bristol-Myers’ popular leukemia drug to improve anti-PD-1 cancer immunotherapy .Because not all patients respond to anti-PD-1/L1 therapies, researchers are exploring new ways to improve their efficacy. Now, a team led by Cedars-Sinai Medical Center scientist has pinpointed Sprycel, a popular blood cancer drug by Bristol-Myers Squibb, as a potential booster.

from FierceBiotech: Biotech https://ift.tt/2Sj9eXu

#news #biotech Cocktail of Molecules Induces Astrocytes to Transform into Neurons

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Cocktail of Molecules Induces Astrocytes to Transform into Neurons .A team of neurobiological researchers developed a simple recipe requiring only three or four small molecules to convert human fetal…

from Drug Discovery | Bio Research International https://ift.tt/2GzDX0N

#news #biotech Cocktail of Molecules Induces Astrocytes to Transform into Neurons

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Cocktail of Molecules Induces Astrocytes to Transform into Neurons .A team of neurobiological researchers developed a simple recipe requiring only three or four small molecules to convert human fetal…

from Genomics/Proteomics | Bio Research International https://ift.tt/2E0hKVT

#news #biotech Establishing the molecular blueprint of early embryo development

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Establishing the molecular blueprint of early embryo development .A team of biologists, physicists and mathematical modellers in Cambridge have studied the genetic activity of over 100,000 embryonic cells to establish the molecular blueprint of mouse early embryo development. This new research provides fundamentally important information on how mammalian embryos develop during gastrulation, a key stage of development, and paves the way for new understanding of the earliest stages of life.

from Biotechnology News – Biology News https://ift.tt/2IAW73Y

#news #biotech Pluristem’s cell therapies head for orbit with NASA deal

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Pluristem’s cell therapies head for orbit with NASA deal .Pluristem has just reached a stellar deal with NASA that will see its cell therapies tested against the health problems caused by spending time in space.

from FierceBiotech: Biotech https://ift.tt/2T6PlHk

#news #biotech Activating tooth regeneration in mice

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Activating tooth regeneration in mice .Most reptiles and fish have multiple sets of teeth during their lifetime. However, most mammals, such as humans, have only one set of replacement teeth and some mammals, like mice, have only a single set with no replacement. This diversity raises both evolutionary questions—how did different tooth replacement strategies evolve?—and developmental ones—which mechanisms prevent replacement teeth in animals that lost them?

from Biotechnology News – Biology News https://ift.tt/2Si32it

#news #biotech Vical stops antifungal trial, lays off staff to eke out cash

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Vical stops antifungal trial, lays off staff to eke out cash .Vical has stopped a phase 2 trial of antifungal VL-2397 and outlined plans to lay off employees. The cost-cutting actions come as Vical tries to eke out its cash while looking into strategic alternatives.

from FierceBiotech: Biotech https://ift.tt/2V7TzMk

#news #biotech Genetic blueprint for extraordinary wood-munching fungus

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Genetic blueprint for extraordinary wood-munching fungus .A relatively unknown fungus, accidentally found growing on an Acacia tree in the Northern Cape, has emerged as a voracious wood-munching organism with enormous potential in industries based on renewable resources.

from Biotechnology News – Biology News https://ift.tt/2GAk0aa